# $rhhby

Roche's fenebrutinib shows promising results in reducing disability progression for multiple sclerosis patients, with significant social media buzz surrounding its potential impact on the market. Analysts are closely watching the stock's reaction to this news.

### About $rhhby
This topic refers to the decentralized digital currency and its associated ecosystem.  

### Insights
- $rhhby sentiment is up 23.46% from the previous week.

### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$rhhby/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$rhhby/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [---] -90%  
[--] Month: [-------] -36%  
[--] Months: [---------] -2.10%  
[--] Year: [---------] -20%  
1-Year High: [-------] on 2025-12-30  
1-Year Low: [---] on 2026-01-19  

Engagements by network (24h):
Reddit: [---]
X: [-----]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$rhhby/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$rhhby/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [---]  
1-Year High: [---] on 2025-08-03  
1-Year Low: [--] on 2025-12-06  

Mentions by network (24h):
Reddit: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$rhhby/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$rhhby/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $rhhby in the last [--] hours which is down 7.50% from [--] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2025-03-06  
1-Year Low: [--] on 2025-09-15  

The most influential creators that mention $rhhby in the last [--] hours

| Creator                                        | Rank | Followers | Posts | Engagements |
| -------                                        | ---- | --------- | ----- | ----------- |
| [@Quantumup1](/creator/twitter/Quantumup1)     | [--]    | [-----]     | [--]     | [-----]       |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)     | [--]    | [-----]     | [--]     | [---]         |
| [@Roche](/creator/twitter/Roche)               | [--]    | [-------]   | [--]     | [---]         |
| [@JoseRestonVA](/creator/twitter/JoseRestonVA) | [--]    | [-----]     | [--]     | [---]         |
| [@MethOSilly](/creator/twitter/MethOSilly)     | [--]    | [--]        | [--]     | [--]           |

[View More](/list/creators/$rhhby/100)
  
  
### Sentiment: 90%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rhhby/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$rhhby/time-series/sentiment.tsv)  
Current Value: 90%  
Daily Average: 79%  
[--] Week: 100% +19%  
[--] Month: 84% +6%  
[--] Months: 84% +34%  
[--] Year: 84% +6%  
1-Year High: 100% on 2025-02-13  
1-Year Low: 40% on 2025-08-09  

Most Supportive Themes:
- Community Building: (45%) Focus on fostering a strong and engaged community through interactive content and discussions.
- Educational Content: (30%) Providing valuable information and insights related to the topic to empower the audience.
  
Most Critical Themes:
- Market Volatility: (60%) Addressing the unpredictable nature of the market and its impact on investments.
- Regulatory Uncertainty: (25%) Highlighting the evolving regulatory landscape and its potential implications.
  

### Top $rhhby Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"@financiern @zipjet @pharmatrader1 I have a position in $TGTX actually Jan [----] $20 calls so I'm not rooting this to be bad for the company. But it's good to know what is going around. No position in $RHHBY but I think this validates the $NRIX BTK brain penetrating degrader"  
[X Link](https://x.com/Andre_AGTC/status/2020298097193275652) [@Andre_AGTC](/creator/x/Andre_AGTC) 2026-02-08T00:46Z [----] followers, [---] engagements


"$RHHBY Fenebrutinib - the FIC in multiple sclerosis. Oral brain-penetrant BTK inhibitor for PPMS and relapsing multiple sclerosis (RMS) - good data compared to IV CD20 OCREVUS Good news for $NRIX Not a good one for $TGTX"  
[X Link](https://x.com/Andre_AGTC/status/2020257017924137316) [@Andre_AGTC](/creator/x/Andre_AGTC) 2026-02-07T22:03Z [----] followers, [----] engagements


"$RHHBY Genentech's Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) More Info: https://pryzm.ozmosi.com/product/12578 https://pryzm.ozmosi.com/product/12578"  
[X Link](https://x.com/OzmosiHealth/status/2020241738401820842) [@OzmosiHealth](/creator/x/OzmosiHealth) 2026-02-07T21:02Z [----] followers, [---] engagements


"$RHHBY Roche's fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS) More Info: https://pryzm.ozmosi.com/product/12578 https://pryzm.ozmosi.com/product/12578"  
[X Link](https://x.com/OzmosiHealth/status/2020241733620314466) [@OzmosiHealth](/creator/x/OzmosiHealth) 2026-02-07T21:02Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing